COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 1346: Articles 13451-13460  | Next

Rotation-based schedules in elementary schools to prevent COVID-19 spread: A simulation study
Brom, C., Diviak, T., Drbohlav, J., Korbel, V., Levinsky, R., Neruda, R., Suchoparova, G., Slerka, J., Smid, M., Trnka, J., Vidnerova, P.
10.1101/2021.06.28.21259628 — Posted: 2021-07-01
Community-Based Phenotypic Study of Safety, Tolerability, Reactogenicity and Immunogenicity of Emergency-Use-Authorized Vaccines Against COVID-19 and Viral Shedding Potential of Post-Vaccination Infections: Protocol for a prospective study
Gabashvili, I. S.
10.1101/2021.06.28.21256779 — Posted: 2021-07-01
Side Effects and Perceptions Following Sinopharm COVID-19 Vaccination
Qubais, B., Al-Shahrabi, R., Alhaj, S. S., Alkokhardi, Z. M., Adrees, A. O.
10.1101/2021.06.28.21258847 — Posted: 2021-07-01
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 infection
Swadling, L., Diniz, M. O., Schmidt, N. M., Amin, O. E., Chandran, A., Shaw, E., Pade, C., Gibbons, J. M., Le Bert, N., Tan, A. T., Tham, C. Y. L., Tan, C., Kucyowicz, S., Aidoo-Micah, G., Rosenheim, J., Davies, J., Jensen, M. P., Joy, G., McCoy, L. E., Valdes, A. M., van Dorp, L., Altmann, D. M., Boyton, R. J., Manisty, C., Treibel, T. A., Moon, J. C., COVIDsortium Investigators, , Balloux, F., McKnight, A., Noursadeghi, M., Bertoletti, A., Maini, M. K.
10.1101/2021.06.26.21259239 — Posted: 2021-07-01
Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda
Frazier, L., Lubinski, B., Tang, T., Daniel, S., Jaimes, J. A., Whittaker, G.
10.1101/2021.06.30.450632 — Posted: 2021-07-01
Infectivity and immune escape of the new SARS-CoV-2 variant of interest Lambda
Acevedo, M. L., Alonso-Palomares, L., Bustamante, A., Gaggero, A., Paredes, F., Cortés, C., Valiente-Echeverría, F., Soto-Rifo, R.
10.1101/2021.06.28.21259673 — Posted: 2021-07-01 Discussion: Onsite | Offsite
Post COVID-19 sequelae: A prospective observational study from Northern India
Naik, S. R., Soneja, M., Haldar, S., Mundadan, N. G., Garg, P., mittal, a., Desai, D., Trilangi, P. K., Chakraborty, S., Begam, N. N., Bhattacharya, B., Maher, G., Kumar, S. S., Jonnalagadda, K., Arunan, B., Gupta, A., Mahishi, N., Rajanna, C., Prasoon, P., Kumar, N. A., Maharatna, S., Bhattacharya, A., Keri, V., Samed, S. A., K, A. A., Shareef, I., Ravela, N., Swain, S., Sarda, R., Kadnur, H. B., Dudhwal, A., Agarwal, A., Vedula, K., Gupta, A., Agarwal, S., R, A., Lalikar, P., Jagtap, P., Bainsla, P., Kodan, P., Sethi, P., Ray, A., Jorwal, P., Kumar, A., Nischal, N., Sinha, S., Biswas, A., Wig, N.
10.1101/2021.06.28.21259658 — Posted: 2021-07-01
Recovery of serum testosterone levels is an accurate predictor of survival from COVID-19 in male patients
Toscano-Guerra, E., Martinez-Gallo, M., Arrese-Munoz, I., Gine, A., Diaz, N., Gabriel-Medina, P., Riveiro-Barciela, M., Labrador-Horrillo, M., Martinez-Valle, F., Hernandez-Gonzalez, M., Rodriguez-Frias, F., Pujol Borrell, R., Ferrer, R., Thomson, T. M., Paciucci, R.
10.1101/2021.06.29.21259693 — Posted: 2021-07-01 Discussion: Onsite
Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection
Drummer, H. E., Van, H., Klock, E., Zheng, S., Wei, Z., Boo, I., Center, R. J., Li, F., Bhat, P., Ffrench, R., Lau, J. S. Y., McMahon, J., Laeyendecker, O., Fernandez, R. E., Manabe, Y. C., Klein, S. L., Quinn, T. C., Anderson, D. A.
10.1101/2021.06.28.21259671 — Posted: 2021-07-01
COVID-19 Has Long Term Effects on Chemosensory Functions
Bussiere, N., Mei, J., Levesque-Boissonneault, C., Blais, M., Carazo, S., Gros-Louis, F., De Serres, G., Dupre, N., Frasnelli, J.
10.1101/2021.06.28.21259639 — Posted: 2021-07-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).